Icon (MEX:ICLRN) Tariff Resilience Score: 9/10 (As of Jun. 27, 2026)


MEX:ICLRN Icon PLC MEX:ICLRN
87 GF Score
Price MXN1,850.28
GF Value MXN2,479.74
! 4 Warning Signs
View Full Analysis

What is Icon Tariff Resilience Score?

Icon MEX:ICLRN 87 Tariff Resilience Score is 9 as of Jun. 27, 2026. GuruFocus rates MEX:ICLRN with a GF Score™ of 87/100 and a GF Value™ of MXN2,479.74. The stock has 4 warning signs investors should review. Among 216 Medical Diagnostics & Research companies, Icon ranks better than 99.54% on this metric.

Icon has the Tariff Resilience Score of 9, which implies that the company might have Highly Resilient.

Icon has Clinical research services with minimal direct tariff exposure. Global operations and client base provide strong resilience against regional trade disruptions.

Tariff Resilience Score is a ranking system developed by GuruFocus to measure a company's exposure to international trade tariffs, rated on a scale from 0 to 10. It takes into account key factors such as global supply chain dependencies, manufacturing locations versus sales markets, import / export balance and percentage of revenue, and more.

The company's exposure to international trade tariffs based on these criteria:

1. Global supply chain dependencies
2. Manufacturing locations versus sales markets
3. Import/export balance and percentage of revenue
4. Historical impact from previous tariff changes
5. Available mitigation strategies (alternative suppliers, pricing power)
6. Industry-specific tariff exemptions or vulnerabilities

Based on the research, GuruFocus believes Icon might have Highly Resilient.

Icon  (MEX:ICLRN) Tariff Resilience Score Explanation

The Tariff Resilience Score ranges from 0 to 10, with 10 as the most resilient. GuruFocus divided Moat Score into following 3 categories:

Tariff Resilience Score Resilience Level
7 - 10Highly Resilient
4 - 6Average Resilient
0 - 3Highly Vulnerable

Icon Tariff Resilience Score Related Terms

MEX:ICLRN vs RVTY, CRL, MEDP: Tariff Resilience Score Comparison

For the Diagnostics & Research subindustry, Icon's Tariff Resilience Score, along with its competitors' market caps and Tariff Resilience Score data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Icon Tariff Resilience Score vs Medical Diagnostics & Research Industry

For the Medical Diagnostics & Research industry and Healthcare sector, Icon's Tariff Resilience Score distribution charts can be found below:

* The bar in red indicates where Icon's Tariff Resilience Score falls into.


MEX:ICLRN
87GF Score
Icon PLC MEX:ICLRN
Tariff Resilience Score is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis
What does a Tariff Resilience Score of 9 mean?
Icon (MEX:ICLRN) has a Tariff Resilience Score of 9 as of Jun. 27, 2026. Tariff Score is a ranking system developed by GuruFocus to measure a company's exposure to international trade tariffs, rated on a scale from 0 to 10. It takes into account key factors such as global supply chain dependencies, manufacturing locations versus sales markets, import / export balance and percentage of revenue, and more. According to the industry distribution chart, Icon ranks #1 out of 216 companies in the Medical Diagnostics & Research industry, placing it in the top 0.5%.
Is Icon's Tariff Resilience Score too high?
Icon's current Tariff Resilience Score is 9. Based on the distribution chart, Icon ranks #1 out of 216 companies in the Medical Diagnostics & Research industry, which is in the top quartile — a strong position relative to peers. Overall, Icon has a GF Score™ of 87/100, reflecting its overall financial health beyond just this single metric.
How does Icon's Tariff Resilience Score compare to RVTY and CRL?
According to the Medical Diagnostics & Research industry distribution chart, Icon ranks #1 out of 216 companies for Tariff Resilience Score. This places Icon in the top 1% of its industry — outperforming the majority of peers. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Tariff Resilience Score for a Medical Diagnostics & Research company?
A good Tariff Resilience Score depends on the Medical Diagnostics & Research industry context. However, Tariff Resilience Score should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Tariff Resilience Score mean?
A high Tariff Resilience Score can signal that a stock is expensive relative to its fundamentals. Tariff Score is a ranking system developed by GuruFocus to measure a company's exposure to international trade tariffs, rated on a scale from 0 to 10. It takes into account key factors such as global supply chain dependencies, manufacturing locations versus sales markets, import / export balance and percentage of revenue, and more. Icon's current Tariff Resilience Score is 9. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Icon stock overvalued right now?
Icon (MEX:ICLRN) has a current Tariff Resilience Score of 9. The stock's GF Value™ is MXN2,479.74, compared to a current price of MXN1,850.28 — trading 25.4% below its estimated fair value. The current Tariff Resilience Score is 9. Icon's overall GF Score™ is 87/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Tariff Resilience Score calculated?
Tariff Resilience Score is calculated from a company's financial statements. For Icon (MEX:ICLRN), the current Tariff Resilience Score is 9 as of Jun. 27, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Icon (MEX:ICLRN) Overvalued in 2026?

Based on GuruFocus' analysis, Icon stock appears to be undervalued. The current stock price of MXN1,850.28 is trading 25.4% below its estimated GF Value™ of MXN2,479.74.

Key valuation signals for MEX:ICLRN:

  • Tariff Resilience Score: 9
  • GF Value™: MXN2,479.74 vs. price of MXN1,850.28 (25.4% below fair value)
  • GF Score™: 87/100 with 4 warning signs

No single metric tells the full story. See the MEX:ICLRN stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Icon Business Description

Address South County Business Park, Leopardstown, Dublin, IRL, D18 X5R3
Icon is a global contract research organization that provides outsourced clinical development services to pharmaceutical and biotechnology firms. Icon supports clients across late-stage clinical trials through the regulatory approval process and postmarket studies. Icon's services include clinical trial management, patient recruitment, data analytics, laboratory services, and regulatory consulting. With more than 40,000 employees operating in over 50 countries, the company partners with life sciences firms to run clinical trials and bring new drugs to market.
87GF Score

Get the complete analysis for MEX:ICLRN

Tariff Resilience Score is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

MXN1,850.28
Price
MXN2,479.74
GF Value